MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 79 filers reported holding MAXCYTE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,707,633 | -7.1% | 1,243,493 | +0.2% | 0.01% | -10.0% |
| Q1 2023 | $6,140,950 | -9.6% | 1,240,596 | -0.2% | 0.01% | -16.7% |
| Q4 2022 | $6,790,203 | -17.8% | 1,243,627 | -2.1% | 0.01% | -20.0% |
| Q3 2022 | $8,261,000 | +36.8% | 1,270,930 | -0.5% | 0.02% | +50.0% |
| Q2 2022 | $6,039,000 | -32.4% | 1,276,698 | -0.2% | 0.01% | -16.7% |
| Q1 2022 | $8,940,000 | -70.0% | 1,278,989 | -56.2% | 0.01% | -65.7% |
| Q4 2021 | $29,835,000 | -20.0% | 2,923,155 | -4.9% | 0.04% | -23.9% |
| Q3 2021 | $37,278,000 | – | 3,074,071 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |